Related Funds
| Fund Name | Location |
| Andlinger and Company | Belgium, Brussels, Brussels Hoofdstedelijk Gewest |
| BDO Unibank | Makati, Manila, Philippines |
| Digital Colony | Boca Raton, Florida, United States |
| DPG Investments | Beverly Hills, California, United States |
| Envision Capital | China, Shanghai |
| Fenghua Capital | China, Hangzhou, Zhejiang |
| Linse Capital | California, Menlo Park, United States |
| Lotus Capital | New York, New York, United States |
| MedCap Advisors | Cambridge, Massachusetts, United States |
| Mithra Ventures | Boston, Massachusetts, United States |
| National Oceanic and Atmospheric Administration | District of Columbia, United States, Washington |
| Scale Lab Andorra | Andorra, Aragon, Spain |
| Skullcandy | Park City, United States, Utah |
| TBD Angels | Boston, Massachusetts, United States |
| The Origin Capital | Central, Central Region, Singapore |
| Wessel Management | Bayern, Germany, München |
| Zhejiang Jingu | China, Fuyang, Zhejiang |
| Zuig Investment | China, Hangzhou, Zhejiang |
– Provepharm Life Solutions, a Marseille-based pharmaceutical company that finds new applications for known molecules.
– The company raised €120M in funding.
– Tikehau Capital will provide the funds joining the group’s pool of banking investors, including Société Générale, BNP Paribas, Banque Populaire Méditerranée, Crédit Agricole Alpes Provence and Bpifrance.
– The new investment will be used to consolidate its position as an international and independent pharmaceutical group, specifically by hiring new staff in France and the United States, and increasing the size of its laboratories in Marseille.
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data 